Status:
COMPLETED
Understanding and Addressing Variations in HAIs After Durable Ventricular Assist Device Therapy
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Healthcare-Associated Infections
Eligibility:
All Genders
18+ years
Brief Summary
Substantial center variability exists in healthcare-associated infection (HAI) rates following durable ventricular assist device (VAD) implantation for patients with advanced heart failure. Preliminar...
Detailed Description
Durable ventricular assist devices (VADs) provide long-term mechanical circulatory support as a bridge to cardiac transplantation or as permanent therapy, and have the potential to benefit more than 2...
Eligibility Criteria
Inclusion
- Female and Male adult patients 18 and over who have received a FDA-approved, durable ventricular assist device implant from 2008 onwards
Exclusion
- Children
Key Trial Info
Start Date :
February 4 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
34958 Patients enrolled
Trial Details
Trial ID
NCT03749434
Start Date
February 4 2019
End Date
June 30 2024
Last Update
July 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109